NSE
Gland Pharma LimitedGLAND
Gland Pharma Limited is a pharmaceutical company that manufactures and markets generic medicines in India and abroad.
| Key products | Generic versions of branded medicines, Specialty injectables |
|---|---|
| Geography | India, USA, Europe |
| Competitors | Dr. Reddy's Laboratories, Cipla Limited, Sun Pharmaceuticals Industries Limited |
AI-generated overview — verify before relying on it.
Net institutional flow
+₹294.7 Cr
Institutional buyers
2 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Rs 18 Per Share
ex 2025-08-14
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | GLANDThis | — | — | — | — | — | — |
| 2 | ACMESOLAR | — | — | — | — | +3 | 6 |
| 3 | AADHARHFC | — | — | — | — | — | — |
| 4 | AARTIIND | — | — | — | — | — | — |
| 5 | ACE | — | — | — | — | — | — |
| 6 | ACUTAAS | — | — | — | — | +4 | 6 |
| 7 | ABLBL | — | — | — | — | — | — |
| 8 | AAVAS | −₹1.9 Cr | 2 | — | — | — | — |
| 9 | ABFRL | −₹142.6 Cr | 2 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-17FilingGland Pharma Limited has informed the Exchange about Schedule of meetInvestor Call
- 2026-06-16FilingGland Pharma Limited has informed the Exchange about Schedule of meetInvestor Call
- 2026-06-16FilingGland Pharma Limited has informed the Exchange regarding 'General'.Updates
- 2026-06-15FilingGland Pharma Limited has informed the Exchange about Resignation of Director/KMP/SMPRisk
- 2026-06-15FilingGland Pharma Limited has informed the Exchange regarding Change in Director(s) of the company.Management
- 2026-06-15FilingGland Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 15, 2026.Board Meeting
- 2026-06-10FilingGland Pharma Limited has informed the Exchange about Copy of Newspaper PublicationCompliance
- 2025-08-14ActionDividend - Rs 18 Per ShareDividend
- 2025-03-21BulkBUY · ₹133.2 CrVANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VIEIF
- 2025-03-21BulkBUY · ₹161.4 CrVANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND
- 2025-03-21NetDay net +₹294.7 Cr
- 2024-08-16ActionAnnual General Meeting/Dividend - Rs 20 Per ShareDividend
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 3
- 3
- 2
- 3
- 2
- 3
- 1
2 deals · 2025-03-21 → 2025-03-21
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2025-03-21 | VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VIEIF | Institution | BUY | ₹133.2 Cr |
| 2025-03-21 | VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND | Institution | BUY | ₹161.4 Cr |
2 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
Financial results
None yet.
News & chatter on GLAND
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.